Final yr, I revealed a paper that confirmed that most cancers mortality charges fell by 24% between 2000 and 2016 and additional that new most cancers medicine accounted for saving 1.three million lives within the US over that point interval. On the finish of the paper, we famous that these numbers could also be conservative since the usage of new improvements–reminiscent of immuno-oncology, CAR-T remedy and others–took off after 2016.
It seems that our premonition was right, primarily based on the findings from the American Most cancers Society’s 2021 Details & Figures report.
From 1991 to 2018, the most cancers demise fee has fallen 31%. This features a 2.4% decline from 2017 to 2018—a brand new report for the most important 1-year drop within the most cancers demise fee.
Enhancements in well being behaviors (e.g., smoking) and new remedies have paved the way in which for this enchancment, significantly for lung most cancers.
Reductions within the lung most cancers demise rateaccount for nearly half of the full drop within the most cancers demise fee from 2014 to 2018. That is regarded as as a consequence of declines in smoking, advances in early detection, and improved remedies, particularly for non-small cell lung most cancers (NSCLC), the commonest subtype.
Notice that the information don’t embrace the affect of COVID-19 as they solely run by way of 2018. Additional, regardless of the dramatic enchancment in mortality, most cancers remains to be the #2 killer within the US (ignoring COVID), simply behind coronary heart illness. Nevertheless, COVID-19 has handed most cancers when it comes to US mortality within the spring and with the current surge has nearly actually surpassed most cancers within the fall/winter of this yr.
As all the time, there’s a lot of attention-grabbing info within the ACS report.